Final review of the Medicines Transparency Alliance Programme (2016): Management response

The main purpose of the review of the Medicines Transparency Alliance programme, phase II, was to provide in-depth information with regard to the achievements and challenges of phase II of this programme, as well as to inform the WHO strategy for future work in transparency and good governance in the pharmaceutical sector in countries.